RENITA ALEXANDER: Open Payments
NPI 1245792506 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 49 payments from 17 companies in 2025. Trend: 2023 $1,354 · 2024 $1,036 · 2025 $1,097
Food & beverage: $1,097
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $207 |
| PFIZER INC. | 9 | $174 |
| Novartis Pharmaceuticals Corporation | 8 | $140 |
| Actelion Pharmaceuticals US, Inc. | 4 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
| Merck Sharp & Dohme LLC | 3 | $72 |
| Boston Scientific Corporation | 3 | $71 |
| Ionis Pharmaceuticals, Inc. | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Edwards Lifesciences Corporation | 1 | $30 |
Products named: CAMZYOS, LEQVIO, ELIQUIS, VYNDAQEL, OPSUMIT, Kerendia, WINREVAIR, TRYNGOLZA.
Industry payments across GA — which companies pay providers there.
